Skip to content

Veradermics MANE Proceeds from issuance of preferred stock

Proceeds from issuance of preferred stock at other companies

Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$0
EquipmentShare.com, Inc.
 logo
EquipmentShare.com, Inc. EQPT
$0
Fluor logo
FluorFLR
$0
American Homes 4 Rent logo
American Homes 4 RentAMH
$67.5M
Popular logo
PopularBPOP
Popular logo
PopularBPOP

Other financials

Income statement

See full
Operating income-$29.9M-131%
Net income-$27.2M-120%
EPS (diluted)-$1.32+93.3%

Balance sheet

See full
Cash & equivalents$168.4M+419%
Total debt$4.0K
Total equity$390.6M+744%
Total assets$397.4M

Cash flow

See full
Operating cash flow-$21.2M-59.0%
CapEx--100%
Free cash flow-$21.2M-58.7%

Valuation

See full
Market cap$3.92B

Returns & leverage

See full
Return on equity-28.7%
Current ratio59.1×

Where this comes from

Reported directly by Veradermics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock.

The official record: Veradermics ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veradermics 's proceeds from issuance of preferred stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veradermics 's proceeds from issuance of preferred stock?
Veradermics (MANE) reported proceeds from issuance of preferred stock of $0 in Q1 2026.